REQUEST A DEMO
Total
USD $0.00
Search more companies

Medtrials Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Medtrials Sp. z o.o. Profile Updated: February 21, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Medtrials Sp. z o.o. is an enterprise based in Poland. Its main office is in Krakow. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on March 26, 2018. From the latest financial highlights, Medtrials Sp. z o.o. reported a net sales revenue drop of 27.16% in 2022. Its total assets grew by 22.13% over the same period. In, 2022, the company’s net profit margin decreased by 32.01%.

Headquarters
Ul. Plac Lasoty 4
Krakow; Malopolskie; Postal Code: 30-539

Contact Details: Purchase the Medtrials Sp. z o.o. report to view the information.

Website: http://-

Basic Information
Outstanding Shares:
Purchase the Medtrials Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medtrials Sp. z o.o. report to view the information.
Incorporation Date:
March 26, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Medtrials Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-27.16%
Total operating revenue
-27.39%
Operating profit (EBIT)
-28.44%
EBITDA
-32.94%
Net Profit (Loss) for the Period
-28.44%
Total assets
22.13%
Total equity
-33.53%
Operating Profit Margin (ROS)
-32.01%
Net Profit Margin
-32.01%
Return on Equity (ROE)
-0.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?